Hydrochloric Acid → 3-[1-[2-[4-(4-Pyridyl)piperazin-1-yl]acetyl]piperidin-4-yl]propanoic acid
Reaction equation
[N:1]1[CH:6]=[CH:5][C:4]([N:7]2[CH2:12][CH2:11][N:10]([CH2:13][C:14]([N:16]3[CH2:21][CH2:20][CH:19]([CH2:22][CH2:23][C:24]([O:26]CC)=[O:25])[CH2:18][CH2:17]3)=[O:15])[CH2:9][CH2:8]2)=[CH:3][CH:2]=1.Cl>O1CCOCC1>[N:1]1[CH:6]=[CH:5][C:4]([N:7]2[CH2:8][CH2:9][N:10]([CH2:13][C:14]([N:16]3[CH2:17][CH2:18][CH:19]([CH2:22][CH2:23][C:24]([OH:26])=[O:25])[CH2:20][CH2:21]3)=[O:15])[CH2:11][CH2:12]2)=[CH:3][CH:2]=1Participants
4
Procedure
A mixture containing ethyl 3-[1-[2-[4-(4-pyridyl)piperazin-1-yl]acetyl]piperidin-4-yl]propanoate (50 mg), concentrated hydrochloric acid (1 ml) and dioxan (4 ml) was stirred at 50°-60° C. for 1 hour, then concentrated to give a foam which was triturated with hot isopropanol. Filtration gave the title compound (48 mg) as pale cream prisms, m.p. 188°-190° C. NMR (d6DMSO+d4AcOH): δ 1.0-1.3(2H,m); 1.5-1.6(3H,m); 1.8(2H,d); 2.3(2H,t); 2.6-2.8(1H,m); 2.95-3.15(1H,m); 3.5(4H,br.s); 3.6-3.7(1H,m); 4.0-4.2(4H,br.s); 4.3-4.5(3H,m); 7.25(2H,d); 8.35(2H,d); m/e 361(M+H)+ ; calculated for C19H28N4O3. 2HCl. H2O: C, 50.6; H, 7.2; N, 12.4; H2O, 4.0; found: C, 50.3; H, 7.2; N, 12.2; H2O, 4.0%.
Workup
- concentrationconcentrated
- customto give a foam which
- customwas triturated with hot isopropanol
- filtrationFiltration
Sources & evidence
- ORD record
- ord-34603cb9784747868e0fbebd20174858
- Source dataset
- uspto-grants-1998_05
- Patent number
- US05753659
Reaction notes
Loading…